Skip to content
Screener

Beta Bionics BBNX Market capitalization

Market capitalization at other companies

Insulet logo
InsuletPODD
$10.55B-51.8%
Tandem Diabetes Care logo
Tandem Diabetes CareTNDM
$1.03B-23.1%
Medtronic logo
MedtronicMDT
$103.96B-3.8%
Embecta Corp. logo
Embecta Corp.EMBC
$193.41M-67.6%
AdaptHealth logo
AdaptHealthAHCO
$1.62B+10.6%
Halozyme Therapeutics logo
Halozyme TherapeuticsHALO
$9.28B+39.8%

Other financials

Income statement

See full
Revenue$32.0M+37.8%
Gross profit$18.9M+51.2%
Operating income-$25.6M-28.7%
Net income-$23.4M-38.7%
EPS (diluted)-$0.53-35.9%

Balance sheet

See full
Cash & equivalents$44.3M+26.4%
Total debt$6.5M-2.6%
Total equity$256.4M-15.0%
Total assets$292.4M-11.4%

Cash flow

See full
Operating cash flow-$14.6M-7.6%
CapEx$1.0M-41.6%
Free cash flow-$15.7M-1.9%

Valuation

See full
Enterprise value$677.53M+14.2%
P/S6×-2.0×

Profitability

See full
Gross margin58.3%+4.4pp
Operating margin-69.8%-8.0pp
Net margin-61.3%-15.8pp
FCF margin-51.6%-13.4pp

Returns & leverage

See full
Return on equity-26.2%—
Debt / equity0×0.0×
Current ratio8.9×-5.8×

Where this comes from

Computed from the period-end share price: $698.28M.

The source filing: Beta Bionics’s 10-Q, filed July 29, 2026. Open the filing →

Filed
Jul 29, 2026, 4:20 PM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0001193125-26-323777

FAQ

What is Beta Bionics's market capitalization?
Beta Bionics (BBNX) reported market capitalization of $698.28M in Q2 2026.
How has Beta Bionics's market capitalization changed year-over-year?
Beta Bionics's market capitalization increased by 2.5% year-over-year, from $681.56M to $698.28M.
What does market capitalization mean?
The total market value of the company's equity at the quarter end (share price × shares outstanding), sampled from daily market data. The latest point tracks the live price.

Ask your AI about Beta Bionics's market capitalization.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude